Why BioSig Technologies (BSGM) Shares Are Down Over 60%

6/11/24 1:52:08 PM ET

Get the next $BSGM alert in real time by email

BioSig Technologies (NASDAQ:BSGM) shares are trading lower by 67% to $0.55 during Tuesday’s session after the company said it was notified by the Nasdaq Hearings Panel that its common stock will be delisted from the Nasdaq Stock Market due to non-compliance with the minimum stockholders’ equity requirement.

Consequently, trading of the company’s stock will be suspended on Nasdaq starting June 12. The stock is expected to trade on the OTC Markets’ Pink Current Information tier under the symbol “BSGM” beginning the same day.

The company intends to request the Panel’s reconsideration and appeal the decision to the Nasdaq Listing and Hearing Review Council, although there is no assurance of success in these efforts.

According to data from Benzinga Pro, BSGM has a 52-week high of $15.50 and a 52-week low of $0.26.

Get the next $BSGM alert in real time by email

Why BioSig Technologies (BSGM) Shares Are Down Over 60%

Chat with this insight

Recent Analyst Ratings for
$BSGM

$BSGM
Leadership Updates

Live Leadership Updates

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP

$BSGM
SEC Filings

SEC Form DEFA14A filed by BioSig Technologies Inc.

SEC Form DEF 14A filed by BioSig Technologies Inc.

SEC Form 10-Q filed by BioSig Technologies Inc.

$BSGM
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

The Benchmark Company initiated coverage on BioSig Technologies with a new price target

$BSGM
Financials

Live finance-specific insights

BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module

BioSig to Host Conference Call on December 21, 2021

$BSGM
Press Releases

Fastest customizable press release news feed in the world

BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement

BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

$BSGM
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$BSGM
Market Insights

Live Market Insights

$BSGM
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Chief Executive Officer Amato Anthony N. was granted 1,550,000 shares, increasing direct ownership by 278% to 2,108,202 units (SEC Form 4)

Director Abelman Steven Eric was granted 30,000 shares, increasing direct ownership by 60% to 80,000 units (SEC Form 4)

Director Baer Christopher Allen was granted 30,000 shares, increasing direct ownership by 60% to 80,000 units (SEC Form 4)

12 Health Care Stocks Moving In Tuesday's After-Market Session

BioSig Technologiesshares are trading lower after the company was notified by the Nasdaq Hearings Panel that its common stock will be delisted from the Nasdaq Stock Market due to non-compliance with the minimum stockholders' equity requirement.